Exchange
Huawei: Helping Carriers Reshape Business, Infrastructure, and O&M with AI
BARCELONA,Spain,March 5,2025-- DuringMWC Barcelona 2025,Huawei is gathering carriers,industry partners,and opinion leaders from around the world to explore the intersection of 5G networks and AI,and h
We Are Enough® Launches the 3.3.3 Challenge: A Global Movement Empowering Women Through Investing in Women
Venture Capitalist Tracy Gray Aims to Address Women\'s Wealth Gap and Access to Capital LOS ANGELES,March 6,2025-- We Are Enough (WAE),a nonprofit,launches the first of its kind initiative,the 3.3.3C
Suvoda launches Sofia, a new AI assistant to simplify management of clinical trials
From many clicks to one query,drug supply managers can more quickly access,analyze,and visualize the trial supply data they need.
ScamAdviser at MWC 2025: Addressing the Rising Threat of AI-Powered Scams
BARCELONA,Spain,March 5,2025-- ScamAdviser,a leading brand in global enterprise scam prevention solutions,spotlighted the escalating threat of AI-driven scams at Mobile World Congress (MWC) 2025 durin
ARK Group Strengthens Singapore Presence with Expanded Overseas Headquarters to Power Global Growth
SINGAPORE,March 5,2025-- Noah Holdings Limited\'s ("Noah" or "the Company") (NYSE: NOAH,HKEX: 6686) newly launched global wealth management platform for global Chinese investors,AR
SanyouBio Launches 73 Whole-Series Bispecific Reference Antibody Products, Facilitating New Breakthroughs in Bispecific Drug Development
SHANGHAI,March 5,2025-- SanyouBio announced today the official launch of 73 whole-series bispecific antibody reference products,covering globally approved and representative clinical-stage bispecific
Hyundai IONIQ 9: Game-changing Electric SUV Offers Long Range, Next-level Comfort, Features and Capabilities
Powerful,efficient performance through multiple motor configurations and a long-range battery for up to 620 km WLTP-estimated range
Suvoda launches Sofia, a new AI assistant to simplify management of clinical trials
From many clicks to one query,drug supply managers can more quickly access,analyze,and visualize the trial supply data they need.
Head-to-Head Against Pembrolizumab: Innovent Announces First Patient Dosed in the First Pivotal Study of IBI363 (PD-1/IL-2α-bias Bispecific Antibody Fusion Protein) in Melanoma
SAN FRANCISCO andSUZHOU,China,March 3,2025-- Innovent Biologics,Inc. ("Innovent") (HKEX: 01801),a world-class biopharmaceutical company that develops,manufactures,and commercializes high-qua